Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) insider Camille Bedrosian sold 10,028 shares of Amylyx Pharmaceuticals stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $32.40, for a total transaction of $324,907.20. Following the completion of the transaction, the insider owned 278,064 shares in the company, […]

Quoin Pharmaceuticals, Ltd. Sponsored ADR (NASDAQ:QNRX – Get Free Report) CEO Michael Myers purchased 20,490 shares of the stock in a transaction on Monday, August 31st. The stock was acquired at an average price of $4.88 per share, with a total value of $99,991.20. Following the acquisition, the chief executive officer directly owned 37,713 shares […]